Predictors of medication adherence in patients with type 2 diabetes mellitus.
about
Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributorsSodium-glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin-metforminBig Data Technologies: New Opportunities for Diabetes ManagementA Comparison of Data Driven-based Measures of Adherence to Oral Hypoglycemic Agents in Medicaid PatientsComparative adherence to diabetes drugs: An analysis of electronic health records and claims data.The Effect of Social Support on Glycemic Control in Patients with Type 2 Diabetes Mellitus: The Mediating Roles of Self-Efficacy and Adherence.Treatment patterns in patients with type 2 diabetes mellitus treated with glucagon-like peptide-1 receptor agonists: Higher adherence and persistence with dulaglutide compared with once-weekly exenatide and liraglutideFailure to reach target glycated a1c levels among patients with diabetes who are adherent to their antidiabetic medication.Retrospective analysis of long-term adherence to and persistence with DPP-4 inhibitors in US adults with type 2 diabetes mellitus.Overview of saxagliptin efficacy and safety in patients with type 2 diabetes and cardiovascular disease or risk factors for cardiovascular disease.Factors associated with adherence to oral antihyperglycemic monotherapy in patients with type 2 diabetesDeterminants of adherence to diabetes medications: findings from a large pharmacy claims database.Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetesType D Personality Predicts Poor Medication Adherence in Chinese Patients with Type 2 Diabetes Mellitus: A Six-Month Follow-Up Study.Efficacy and Acceptability of Glycemic Control of Glucagon-Like Peptide-1 Receptor Agonists among Type 2 Diabetes: A Systematic Review and Network Meta-AnalysisGlycaemic Control and Associated Self-Management Behaviours in Diabetic Outpatients: A Hospital Based Observation Study in Lusaka, Zambia.Predicting Noninsulin Antidiabetic Drug Adherence Using a Theoretical Framework Based on the Theory of Planned Behavior in Adults With Type 2 Diabetes: A Prospective Study.Prescription Factors Associated with Medication Non-adherence in Japan Assessed from Leftover Drugs in the SETSUYAKU-BAG Campaign: Focus on Oral Antidiabetic Drugs.Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study.Comparison of adherence and persistence among adults with type 2 diabetes mellitus initiating saxagliptin or linagliptin.Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in JapanMedication Adherence Mediates the Association between Type D Personality and High HbA1c Level in Chinese Patients with Type 2 Diabetes Mellitus: A Six-Month Follow-Up Study.Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference Study.Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United Kingdom.Choosing wisely in case of hypertension, diabetes and hyperlipidemia in older patients.Practical Considerations for the Use of Subcutaneous Treatment in the Management of Dyslipidaemia.Adherence, persistence, and treatment discontinuation with sitagliptin compared with sulfonylureas as add-ons to metformin: A retrospective cohort database study.Relationship Between Health Literacy and Unintentional and Intentional Medication Nonadherence in Medically Underserved Patients With Type 2 Diabetes.The role of social support on the relationship of depressive symptoms to medication adherence and self-care activities in adults with type 2 diabetes.Oral antidiabetic drug use and associated health outcomes in cancer patients.Retrospective study of adherence to glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes mellitus in the United States.Variation in adherence to medications across the healthcare system in two comparative effectiveness research cohorts.Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes.Ways Health Care Providers Can Promote Better Medication Adherence.The relationship between comorbidity medication adherence and health related quality of life among patients with cancer
P2860
Q26741537-C356DED2-8F5E-466A-8951-746BB71CDDE2Q26752815-5CDF400F-91DB-4555-AA26-6DDA17915D99Q28606802-10AC9AB0-51BC-476F-84F3-96C044548EB9Q30947003-90690118-75FA-4095-ACFC-4F343A5FDAC9Q31171523-96B6264D-F1E0-4D91-BEE7-050191A07E32Q33775803-9142B02C-12E3-43DA-9F67-262BE04C5EC4Q33835762-0C37E2DD-0168-4FE1-8632-750DA90405D1Q34113909-B85B8851-A12A-4860-9F17-81CB214DB1A9Q34737169-4D6EC07F-94FA-4495-BABA-938AC9E97161Q34783302-875066B3-C7B1-4315-B055-6EFBD1CE02B7Q35043805-17EE8656-5994-4CE5-B3DE-A3C21E78C1E7Q35207927-09326050-E1CA-4D0F-B4C6-96ABE1FD0407Q35766301-8FE21F7D-13AF-4470-A915-5EAAB12F59EBQ35928514-5CA51FE8-8222-47D9-ACC8-00392996416AQ36011993-69964A1D-04BC-4878-95AA-B1DC59AD9E3FQ36424142-C25E9E58-7E6F-4F11-88C2-32A3951D2C25Q36822237-E21CAD4A-D0A8-452A-BEC2-6A3F759E6824Q37110232-3EA478DB-8274-489B-8832-26727E6EF3D6Q37133779-6C70EACD-DC01-42B0-AD1E-54888FA15273Q37164571-38D4166C-D6F6-43EC-82C5-55484A4B09FCQ37227402-8C0F3196-2125-4DCE-A174-1CFABAFF2CF1Q37661187-3AF93A05-AA6F-4050-9A34-83A9027DDD0BQ37737456-364E98E2-EE3E-4331-B2CD-07FCD39A57DCQ37737463-6F4D90C6-47F3-42BE-9EE9-A3F68809E8FFQ38711884-DE559F8A-F55E-4086-BE1D-B1326F5B71D1Q39440767-2506E787-E3B4-4D10-9C3B-D04C3FA19D57Q39484148-6DB4A33D-7447-47CC-9854-ACA38BDB87A9Q40111327-0019A146-F117-42DC-B72C-B249937E93CEQ40937724-1388C9A7-919B-4258-83F6-83EFD4B321CDQ45038805-9662E293-A14D-416C-B512-EACF8DCB96BCQ45099109-36EC3A29-624E-4486-91C7-1F77E7A67BD7Q47778300-3CE4E36A-5C85-4F40-B476-DB62A295A1CBQ53623499-45ACFE2E-B7E7-4AB6-B502-6422C63D725DQ55395166-868EF3CA-4E68-4737-845A-0A31297F59AEQ57192928-C7A84A2B-D37F-4F41-8478-17E85FCA6456
P2860
Predictors of medication adherence in patients with type 2 diabetes mellitus.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Predictors of medication adherence in patients with type 2 diabetes mellitus.
@en
Predictors of medication adherence in patients with type 2 diabetes mellitus.
@nl
type
label
Predictors of medication adherence in patients with type 2 diabetes mellitus.
@en
Predictors of medication adherence in patients with type 2 diabetes mellitus.
@nl
prefLabel
Predictors of medication adherence in patients with type 2 diabetes mellitus.
@en
Predictors of medication adherence in patients with type 2 diabetes mellitus.
@nl
P2093
P1476
Predictors of medication adherence in patients with type 2 diabetes mellitus.
@en
P2093
Audrey J Weiss
Kelly F Bell
Nina Thomas
Paul L Juneau
Suellen M Curkendall
P304
P356
10.1185/03007995.2013.821056
P407
P577
2013-07-23T00:00:00Z